Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-03-20 00:00:00 ET · period of report 2023-03-16 · accession 0001415889-23-005236 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | — | +5,396 | 38.1K | +17% | — |
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Paolini John F. | Chief MEDICAL Off | F - Tax | $11.23 | -1,585 | 40.1K | -4% | -$17.8K |
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $0.00 | -5,396 | 3,450 | -61% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-03-20 | M | A | 3,671 | — | 41,224 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 2 | Common | Class A Common Share | 2023-03-16 | F | D | 507 | $11.46 | 37,553 | D | — | — | |
| 3 | Common | Class A Common Share | 2023-03-20 | F | D | 1,078 | $11.12 | 40,146 | D | — | — | |
| 4 | Common | Class A Common Share | 2023-03-16 | M | A | 1,725 | — | 38,060 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 5 | Derivative | Restricted Share Unit | 2023-03-20 | M | D | 3,671 | $0.00 | 0 | D | — · — to — | 3,671 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F3) The performance criteria for these RSUs were met. The RSUs vested in a single installment on March 20, 2023; there was no expiration date for the RSUs. |
| 6 | Derivative | Restricted Share Unit | 2023-03-16 | M | D | 1,725 | $0.00 | 3,450 | D | — · — to — | 1,725 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. |